Platelet Rich Plasma vs Corticosteroids for Hip Osteoarthritis

Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain

Recruiting Phase 4 Interventional Study
Hip Osteoarthritis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 80
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Treatment
Participants needed
54 (estimated)
Sponsor
LifeBridge Health · Other
Who this trial is looking for

This trial is looking for adults with hip osteoarthritis. Participants will receive either a platelet-rich plasma injection or a corticosteroid injection to help reduce their pain and improve function.

Are You a Good Fit for This Trial?
Rules you out Diabetes Mellitus

You may be able to join if

  • I am between 21 and 80 years old.
  • I have been diagnosed with hip osteoarthritis.
  • I am willing to follow all study procedures.
  • I can provide signed consent to take part.
  • I am available for the entire study duration.
  • I need a hip injection to relieve my hip pain.

You may not be able to join if

  • I have had an injection in my hip in the past three months.
  • I have a current skin infection over my hip.
  • I have been diagnosed with chronic pain in the past.
  • I am currently taking opioids as directed.
  • I am allergic to any of the injection ingredients.
  • I have diabetes.
  • If I am female, I am pregnant or planning to become pregnant.
  • I have a medical condition that would prevent me from participating.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

Prospective, single-center that may go on to being multicenter, randomized trial comparing platelet rich plasma (PRP) versus corticosteroid injection for the treatment of symptoms of Hip osteoarthritis. The purpose of the study is to determine which therapy provides a greater reduction in patient reported outcome measures of pain and function.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Male or female, aged 21-80 years * Radiographic diagnosis of Kellgren-Lawrence (KL) grade of II or III Hip osteoarthrit…
Contacts

Martin Gesheff, DHSc

410-601-9467

mgesheff@lifebridgehealth.org

CONTACT